ARTICLE 1 DEFINITIONSConfirmation • May 4th, 2011 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 4th, 2011 Company Industry JurisdictionThis Pricing Supplement is subject to the Confirmation dated as of March 1, 2011 (the “Confirmation”) between J.P. Morgan Securities LLC, as agent for JPMorgan Chase Bank, National Association, London Branch (the “Seller”), and Myriad Genetics, Inc., a Delaware corporation (the “Purchaser”). Capitalized terms used herein have the meanings set forth in the Confirmation.